Key issues, guidelines and tools
For King County health care professionals
Animal and bat bites
- Assessment, Management, and Reporting of Animal and Bat Bites in King County: Information Health Advisories & Resources
- Updated Interim Guidance for Laboratory Testing of Persons with Suspected Infection with Avian Influenza A (H5N1) Virus in the United States
Enhanced surveillance of chronic hepatitis in King County
Acute and chronic hepatitis B and C are legally notifiable conditions in Washington state. Public Health – Seattle & King County (Public Health), in partnership with the Washington Department of Health and the Centers for Disease Control and Prevention, is conducting enhanced surveillance of chronic hepatitis to improve our understanding of the epidemiology of chronic hepatitis in King County by collecting complete and accurate data on demographics, risk factors, clinical information, and clinical management. These documents are available here for your information below.
Health care providers will receive a four-page fax from Public Health including:
- letter/fax cover sheet:
- two-page questionnaire to complete:
- one-page document on the management of persons with chronic hepatitis B or C:
Here is what we ask of health care providers who receive a letter requesting additional information on their patient:
- Please complete and return the questionnaire in 5 days to our secure fax at 206-296-4803.
- The questionnaire takes about 10 minutes to complete. Please answer all questions fully.
- You or a qualified staff member may complete the questionnaire. Patient authorization is not required for you to disclose the information requested; providers are authorized under the HIPAA Privacy Rule, Section 164.512(b), to disclose protected health information to a public health authority for the purpose of public health surveillance, investigations, and interventions.
- We may be contacting the patient named on the questionnaire via telephone and/or mail to conduct a brief interview about chronic hepatitis. If the patient is not aware of their chronic hepatitis status, please inform them at your earliest convenience. Please also advise the patient that Public Health may be calling, and encourage them to participate in the interview. Please indicate on the questionnaire if the patient requires an interpreter for the interview.
Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Guidelines For Evaluation & Management of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections In Outpatient Settings (Updated 1/08, PDF)
- Guidelines for Management of S. aureus Skin & Soft Tissue Infection, Flow Chart, December, 2007 (PDF)
- Methicillin-resistant Staphylococcus aureus (MRSA) facts